Insider Transactions in Q3 2021 at Kronos Bio, Inc. (KRON)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 07
2021
|
Christopher Dinsmore Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,189
-8.71%
|
$192,969
$21.91 P/Share
|
|
Sep 07
2021
|
Christopher Dinsmore Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,189
+8.01%
|
$27,567
$3.27 P/Share
|
|
Aug 20
2021
|
Marianne De Backer Director |
BUY
Open market or private purchase
|
Direct |
1,000
+27.53%
|
$19,000
$19.57 P/Share
|
|
Aug 02
2021
|
Christopher Dinsmore Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,189
-8.71%
|
$183,780
$20.59 P/Share
|
|
Aug 02
2021
|
Christopher Dinsmore Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,189
+8.01%
|
$27,567
$3.27 P/Share
|